Published on 9/19/2007 in the Prospect News PIPE Daily.
New Issue: Entelos arranges £1 million private placement of shares
By Laura Lutz
Des Moines, Sept. 19 - Entelos, Inc. negotiated a private placement of shares for £1 million.
Abingworth Bioventures IIa LP has agreed to buy 3,783,314 shares at 26.55p each. The price per share is a 6.2% premium to the share price on Sept. 18.
Following the placement, Abingworth will own about 13.9% of the enlarged share capital of Entelos.
Entelos is a pharmaceutical company based in Foster City, Calif.
| Issuer: | Entelos, Inc.
|
| Issue: | Shares
|
| Amount: | £1,004,470
|
| Shares: | 3,783,314
|
| Price: | 26.55p
|
| Warrants: | No
|
| Investor: | Abingworth Bioventures IIa LP
|
| Pricing date: | Sept. 18
|
| Stock symbol: | London: ENTL
|
| Stock price: | 25.00p at close Sept. 18
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
